Showing 1511-1520 of 3229 results for "".
Closing Gaps in Care for People of Color with Psoriatic Disease
https://practicaldermatology.com/programs/practical-dermatology/closing-gaps-in-care-for-people-of-color-with-psoriatic-disease/18190/Black, Hispanic, Asian, and other people of color with plaque psoriasis and psoriatic arthritis often face delayed diagnosis, misdiagnosis, and limited access to testing, treatment, and care. Determi-Nation, a new initiative sponsored by Janssen Pharmaceuticals, aims to change this. Patient advocateFrax Pro and CoolSculpting Elite Launch, Antibiotic Resistance in Rosacea, Thriving in Aesthetics Rolls Out
https://practicaldermatology.com/series/dermwire-tv/frax-pro-and-coolsculpting-elite-launch-antibiotic-resistance-in-rosacea-thriving-in-aesthetics-rolls-out/19896/The majority of rosacea patients have never heard of antibiotic resistance, a new survey reported by the National Rosacea Society finds. Candela’s Frax Pro system is now available, featuring Frax 1550 and the novel Frax 1940 applicators. Allergan Aesthetics, an AbbVie company, is launching CoolSculpThe Mind-Skin Connection: Psoriasis and Psychological Comorbidities
https://practicaldermatology.com/issues/supplements/the-mind-skin-connection-psoriasis-and-psychological-comorbidities/20833/An atypical presentation of unilateral, linear, hypertrophic lichen planus in a Patient with HIV
https://practicaldermatology.com/youngmd-connect/resident-resource-center/an-atypical-presentation-of-unilateral-linear-hypertrophic-lichen-planus-in-a-patient-with-hiv/20875/New Frontiers in Neurotoxins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-frontiers-in-neurotoxins/21638/Recent innovations offer patients greater variety and potentially better outcomes.Letter to the Editor
https://practicaldermatology.com/columns/letter-to-the-editor/letter-to-the-editor-2/23905/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-28/23605/Therapeutics Update
https://practicaldermatology.com/topics/psoriasis/therapeutics-update/20530/New products and pharmacologic developmentsPipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Cosmeceuticals: A Clinician's Guide to Science, Selection, Marketing, and Dispensing
https://practicaldermatology.com/topics/general-topics/cosmeceuticals-a-clinicians-guide-to-science-selection-marketing-and-dispensing/22007/Experienced physicians describe dispensing strategies that provide the greatest benefit to the patient and the practice.